Active

PHARMANEXT

Switched

BE0705998068

Rechtspersoon Private limited company 2 establishments

Solbossquare 30, 1050 Elsene Detailhandel in farmaceutische producten

Active for

7 year, 11 months

Financials

Financial year 2025

Gross margin

€ 485,409

▲ 7% vs 2024

Profit

Growing

€ 169,596

▲ 22% vs 2024

Debts

Normal

€ 1.8 million

▲ 130% vs 2024

PHARMANEXT from Elsene, company number BE0705998068, closed financial year 2025 with a result of € 169,596 after tax. For that financial year PHARMANEXT recorded a gross margin of € 485,409 and equity of € 531,183. Compared with financial year 2024, the result moved from € 139,464 to € 169,596. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 26, 2026.

What happened at PHARMANEXT?

What happened at PHARMANEXT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 169,596 (▲ 22% vs 2024). Source: NBB ↗
  • New establishment in Mouscron. KBO
  • New establishment in Elsene. KBO
  • Start of the company according to the CBE. KBO

In short

From € 83,511 profit in 2021 to € 169,596 profit in 2025.

Paid € 156,597 in corporate taxes since 2021.

Best year ever: 2025, with € 169,596 profit.

On average € 134,800 of value added per employee in 2025.

A new publication or filing at PHARMANEXT? We notify you, reason included.

Follow PHARMANEXT

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

PHARMANEXT

Behind PHARMANEXT is Bluestone SRL. It owns 100% of Aclot Pharma itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Bluestone SRL

Director · represented by Ransart Paul

Also active at: COMPAGNIE FINANCIERE ET IMMOBILIERE DE LA DYLE, PHARMACIE de BARRY, PALATINE +11 more

Establishments

Establishment units

Physical locations of this company

Registered office

Solbossquare 30

1050 Elsene

2.285.007.917

Iseghemstraat 161

7700 Mouscron

Active since 1 December 2018

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0705.998.068
VAT number
BE 0705.998.068
Registered office
Solbossquare 30, 1050 Elsene
Names & denominations
PHARMANEXT
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
28 September 2018
Peppol
Active · Active since 9 Dec 2025
Activities · NACE

Detailhandel in farmaceutische producten

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Frequently asked questions

What is the enterprise number of PHARMANEXT?
The enterprise number of PHARMANEXT is BE0705998068.
What is the address of PHARMANEXT?
The registered office of PHARMANEXT is located at Solbossquare 30, 1050 Elsene.
When was PHARMANEXT founded?
PHARMANEXT was founded on 28 September 2018.
What is the main activity of PHARMANEXT?
The main activity of PHARMANEXT is "Detailhandel in farmaceutische producten" (NACE code 47730).
Does PHARMANEXT have a website?
No website is currently known for PHARMANEXT.
How much profit did PHARMANEXT make in 2025?
PHARMANEXT posted a profit after taxes of € 169,596 in financial year 2025.
What is the revenue of PHARMANEXT?
As a small company, PHARMANEXT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 485,409.
How many employees does PHARMANEXT have?
According to the 2025 annual accounts, PHARMANEXT has 3.6 full-time equivalents (FTE).
Where can I find the annual accounts of PHARMANEXT?
PHARMANEXT files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of PHARMANEXT?
According to the 2025 annual accounts, the directors of PHARMANEXT are: Bluestone SRL.
Who owns PHARMANEXT?
Behind PHARMANEXT is Bluestone SRL. It owns 100% of Aclot Pharma itself.